Tempest Therapeutics, Inc.Tempest Therapeutics, Inc.Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc.

No trades
See on Supercharts

Price target

19.500.000.00%
The 4 analysts offering 1 year price forecasts for TPST have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to TPST in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


TPST EPS for the last quarter is −0.42 USD despite the estimation of −0.40 USD. In the next quarter EPS is expected to reach −0.36 USD. Track more of Tempest Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Tempest Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Tempest Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, TPST price target is 19.50 USD with a max estimate of 47.00 USD and a min estimate of 8.00 USD. Check if this forecast comes true in a year, meanwhile watch Tempest Therapeutics, Inc. stock price chart and keep track of the current situation with TPST news and stock market news.
We've gathered opinions of 5 analysts rating TPST stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.